NCT05277376View on ClinicalTrials.gov

Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

October 28, 2022

Study Completion Date

October 28, 2022

Conditions
PharmacokineticsAbsorption; Chemicals
Interventions
DRUG

Bemotrizinol (6%)

Active sunscreen ingredient (Broad spectrum UV-Filter)

Trial Locations (1)

53095

Spaulding Clinical Research LLC, West Bend

All Listed Sponsors
lead

DSM Nutritional Products, Inc.

INDUSTRY